Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
28.85
+2.09 (7.81%)
At close: Aug 26, 2026, 4:00 PM EDT
28.33
-0.52 (-1.80%)
After-hours: Aug 26, 2026, 7:41 PM EDT

Cue Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
17.3927.1422.4648.5151.6164.37
Short-Term Investments
0.021.090.930.2924.68-
Cash & Short-Term Investments
17.4128.2323.3948.876.2964.37
Cash Growth
-37.72%20.70%-52.08%-36.03%18.52%-24.15%
Accounts Receivable
5.385.550.951.70.063.14
Other Receivables
-1.9----
Receivables
5.387.450.951.70.063.14
Prepaid Expenses
1.931.310.810.960.840.87
Other Current Assets
1.9----0.08
Total Current Assets
26.6236.9825.1451.4577.1968.47
Property, Plant & Equipment
3.214.324.847.1210.711.92
Other Long-Term Assets
0.870.912.212.963.393.01
Total Assets
30.7142.2132.1961.5391.2883.4

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.753.952.823.52.732.59
Accrued Expenses
14.881.612.914.143.554.62
Current Portion of Long-Term Debt
--4.333.961.96-
Current Portion of Leases
1.631.913.543.373.34.93
Current Unearned Revenue
-5.340.092.11-0.65
Other Current Liabilities
0.960.69---0
Total Current Liabilities
21.2213.4913.6917.0811.5512.79
Long-Term Debt
---4.28.04-
Long-Term Leases
1.452.2913.166.025.12
Other Long-Term Liabilities
5.73-----
Total Liabilities
28.415.7814.6924.4525.617.91

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.10.060.050.040.03
Additional Paid-In Capital
529.02394.8359.3338.23316.19262.91
Retained Earnings
-526.71-368.47-341.86-301.19-250.46-197.45
Comprehensive Income & Other
-----0.1-
Shareholders' Equity
2.3126.4317.537.0965.6865.49
Total Liabilities & Equity
30.7142.2132.1961.5391.2883.4

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
3.084.28.8814.719.3210.05
Net Cash (Debt)
14.3424.0314.5134.1156.9754.32
Net Cash Growth
-29.47%65.60%-57.45%-40.14%4.89%-30.11%
Net Cash Per Share
3.167.617.7322.3647.9452.09
Filing Date Shares Outstanding
7.263.262.061.621.441.1
Total Common Shares Outstanding
5.233.222.061.571.431.07
Working Capital
5.4123.4911.4534.3765.6455.68
Book Value Per Share
0.448.218.4923.5645.7861.01
Tangible Book Value
2.3126.4317.537.0965.6865.49
Tangible Book Value Per Share
0.448.218.4923.5645.7861.01
Machinery
3.913.794.034.295.625.55
Leasehold Improvements
0.120.120.120.120.120.01
SEC Filings: 10-K · 10-Q